Original data (with adjusted standard errors for multi-arm studies):

              treat1       treat2      TE   seTE seTE.adj.f seTE.adj.r narms multiarm
5            placebo     zolpidem -0.4505 0.1385     0.2224     0.3097     3        *
5           zaleplon     zolpidem -0.1712 0.1104     0.1223     0.2707     3        *
5            placebo     zaleplon -0.2793 0.1142     0.1279     0.2747     3        *
6        eszopiclone      placebo  0.4040 0.1026     0.1026     0.2228     2         
25           placebo     zaleplon -0.0413 0.1196     0.1374     0.2780     3        *
25           placebo     zolpidem -0.3306 0.1396     0.1966     0.3060     3        *
25          zaleplon     zolpidem -0.2893 0.1227     0.1428     0.2816     3        *
32           placebo     zaleplon  0.0294 0.1195     0.1369     0.2777     3        *
32          zaleplon     zolpidem -0.3039 0.1235     0.1439     0.2823     3        *
32           placebo     zolpidem -0.2745 0.1402     0.1978     0.3066     3        *
39           placebo     zolpidem -0.4275 0.1239     0.1239     0.2334     2         
43           placebo     zaleplon -0.1360 0.1054     0.1054     0.2241     2         
45           placebo   suvorexant -0.2000 0.0829     0.0829     0.2145     2         
46           placebo   suvorexant -0.4000 0.0870     0.0870     0.2161     2         
47           placebo     zolpidem -1.2938 0.4804     0.4804     0.5195     2         
48          zaleplon     zolpidem -0.1046 0.1337     0.1337     0.2388     2         
50  BZD-intermediate     zolpidem -0.6721 0.3211     0.3211     0.3772     2         
58       eszopiclone      placebo  0.6757 0.0841     0.0841     0.2149     2         
59           placebo     zolpidem -0.6977 0.0748     0.0748     0.2115     2         
60           doxepin      placebo  0.4235 0.1788     0.1788     0.2667     2         
63           doxepin      placebo  0.1905 0.1258     0.1258     0.2344     2         
65         melatonin      placebo  0.3413 0.2160     0.2160     0.2929     2         
67  BZD-intermediate      placebo  1.7164 0.1167     0.1167     0.2297     2         
70         melatonin      placebo -0.5156 0.3214     0.3214     0.3774     2         
72          BZD-long    BZD-short -0.0000 0.4082     0.5000     0.5556     3        *
72         BZD-short      placebo  0.0000 0.4082     0.5000     0.5556     3        *
72          BZD-long      placebo  0.0000 0.4082     0.5000     0.5556     3        *
77       eszopiclone      placebo  0.6503 0.1286     0.1286     0.2360     2         
81           placebo     zolpidem -1.1706 0.6248     0.6248     0.6554     2         
94  BZD-intermediate     zolpidem  0.2380 0.3177     0.3177     0.3743     2         
99      daridorexant     zolpidem -0.0319 0.1579     0.1821     0.3030     3        *
99           placebo     zolpidem -0.2079 0.1828     0.2594     0.3462     3        *
99      daridorexant      placebo  0.1760 0.1581     0.1824     0.3033     3        *
100        melatonin      placebo  0.1894 0.1894     0.1894     0.2739     2         
102          placebo     zolpidem -0.6990 0.1965     0.1965     0.2788     2         
106      eszopiclone    zopiclone  0.0835 0.1419     0.1419     0.2434     2         
111 BZD-intermediate      placebo  1.0047 0.3468     0.4375     0.4997     3        *
111 BZD-intermediate trimipramine  0.2783 0.3300     0.3954     0.4635     3        *
111          placebo trimipramine -0.7264 0.3361     0.4091     0.4756     3        *
112          placebo     zolpidem -0.5690 0.2140     0.2140     0.2914     2         
120      eszopiclone      placebo  0.3387 0.1392     0.1392     0.2419     2         
123      eszopiclone      placebo  0.4555 0.2344     0.2344     0.3067     2         
127          placebo    ramelteon -0.1953 0.0651     0.0651     0.2083     2         
128 BZD-intermediate     zolpidem -0.0118 0.1432     0.1432     0.2442     2         
129        melatonin      placebo  0.1351 0.1096     0.1096     0.2261     2         
130        melatonin      placebo  0.2146 0.0746     0.0746     0.2114     2         
132          placebo    trazodone -0.2151 0.1414     0.1732     0.2978     3        *
132        trazodone     zolpidem  0.0331 0.1421     0.1751     0.2989     3        *
132          placebo     zolpidem -0.1820 0.1406     0.1712     0.2967     3        *
136      eszopiclone      placebo  0.7984 0.0760     0.0760     0.2119     2         
137          placebo     zolpidem -0.4431 0.1440     0.1440     0.2447     2         
142 BZD-intermediate      placebo  1.1456 0.3701     0.3701     0.4196     2         
144      eszopiclone      placebo  0.3309 0.1260     0.1260     0.2345     2         
145          placebo    ramelteon -0.1428 0.1219     0.1219     0.2324     2         
146      eszopiclone    zopiclone  0.0000 0.1333     0.1333     0.2386     2         
149 BZD-intermediate    trazodone -0.1438 0.1828     0.1828     0.2693     2         
153      lemborexant     zolpidem -0.0367 0.0753     0.0844     0.2555     3        *
153          placebo     zolpidem -0.4217 0.0933     0.1367     0.2730     3        *
153      lemborexant      placebo  0.3851 0.0822     0.0956     0.2613     3        *
155      lemborexant      placebo  0.3810 0.0719     0.0719     0.2105     2         
159     daridorexant      placebo  0.2747 0.0699     0.0699     0.2098     2         
160     daridorexant      placebo  0.2498 0.0808     0.0808     0.2137     2         
162          placebo   quetiapine -0.0506 0.5564     0.5564     0.5906     2         
170 BZD-intermediate  eszopiclone  0.1236 0.2159     0.2159     0.2928     2         

Number of treatment arms (by study):
    narms
5       3
6       2
25      3
32      3
39      2
43      2
45      2
46      2
47      2
48      2
50      2
58      2
59      2
60      2
63      2
65      2
67      2
70      2
72      3
77      2
81      2
94      2
99      3
100     2
102     2
106     2
111     3
112     2
120     2
123     2
127     2
128     2
129     2
130     2
132     3
136     2
137     2
142     2
144     2
145     2
146     2
149     2
153     3
155     2
159     2
160     2
162     2
170     2

Results (fixed effects model):

              treat1       treat2     SMD             95%-CI     Q leverage
5            placebo     zolpidem -0.5166 [-0.5850; -0.4483]  0.09        .
5           zaleplon     zolpidem -0.3125 [-0.4095; -0.2156]  1.33        .
5            placebo     zaleplon -0.2041 [-0.2992; -0.1091]  0.35        .
6        eszopiclone      placebo  0.6027 [ 0.5241;  0.6813]  3.75     0.15
25           placebo     zaleplon -0.2041 [-0.2992; -0.1091]  1.40        .
25           placebo     zolpidem -0.5166 [-0.5850; -0.4483]  0.90        .
25          zaleplon     zolpidem -0.3125 [-0.4095; -0.2156]  0.03        .
32           placebo     zaleplon -0.2041 [-0.2992; -0.1091]  2.91        .
32          zaleplon     zolpidem -0.3125 [-0.4095; -0.2156]  0.00        .
32           placebo     zolpidem -0.5166 [-0.5850; -0.4483]  1.50        .
39           placebo     zolpidem -0.5166 [-0.5850; -0.4483]  0.52     0.08
43           placebo     zaleplon -0.2041 [-0.2992; -0.1091]  0.42     0.21
45           placebo   suvorexant -0.2952 [-0.4128; -0.1776]  1.32     0.52
46           placebo   suvorexant -0.2952 [-0.4128; -0.1776]  1.45     0.48
47           placebo     zolpidem -0.5166 [-0.5850; -0.4483]  2.62     0.01
48          zaleplon     zolpidem -0.3125 [-0.4095; -0.2156]  2.42     0.14
50  BZD-intermediate     zolpidem  0.4551 [ 0.3100;  0.6001] 12.32     0.05
58       eszopiclone      placebo  0.6027 [ 0.5241;  0.6813]  0.75     0.23
59           placebo     zolpidem -0.5166 [-0.5850; -0.4483]  5.86     0.22
60           doxepin      placebo  0.2676 [ 0.0659;  0.4693]  0.76     0.33
63           doxepin      placebo  0.2676 [ 0.0659;  0.4693]  0.38     0.67
65         melatonin      placebo  0.1783 [ 0.0690;  0.2876]  0.57     0.07
67  BZD-intermediate      placebo  0.9717 [ 0.8301;  1.1134] 40.73     0.38
70         melatonin      placebo  0.1783 [ 0.0690;  0.2876]  4.66     0.03
72          BZD-long    BZD-short -0.0000 [-0.8002;  0.8002]  0.00        .
72         BZD-short      placebo  0.0000 [-0.8002;  0.8002]  0.00        .
72          BZD-long      placebo  0.0000 [-0.8002;  0.8002]  0.00        .
77       eszopiclone      placebo  0.6027 [ 0.5241;  0.6813]  0.14     0.10
81           placebo     zolpidem -0.5166 [-0.5850; -0.4483]  1.10     0.00
94  BZD-intermediate     zolpidem  0.4551 [ 0.3100;  0.6001]  0.47     0.05
99      daridorexant     zolpidem -0.2430 [-0.3579; -0.1280]  1.34        .
99           placebo     zolpidem -0.5166 [-0.5850; -0.4483]  1.42        .
99      daridorexant      placebo  0.2737 [ 0.1777;  0.3696]  0.29        .
100        melatonin      placebo  0.1783 [ 0.0690;  0.2876]  0.00     0.09
102          placebo     zolpidem -0.5166 [-0.5850; -0.4483]  0.86     0.03
106      eszopiclone    zopiclone  0.0392 [-0.1513;  0.2296]  0.10     0.47
111 BZD-intermediate      placebo  0.9717 [ 0.8301;  1.1134]  0.01        .
111 BZD-intermediate trimipramine  0.2624 [-0.2990;  0.8238]  0.00        .
111          placebo trimipramine -0.7093 [-1.2714; -0.1473]  0.00        .
112          placebo     zolpidem -0.5166 [-0.5850; -0.4483]  0.06     0.03
120      eszopiclone      placebo  0.6027 [ 0.5241;  0.6813]  3.60     0.08
123      eszopiclone      placebo  0.6027 [ 0.5241;  0.6813]  0.39     0.03
127          placebo    ramelteon -0.1837 [-0.2963; -0.0710]  0.03     0.78
128 BZD-intermediate     zolpidem  0.4551 [ 0.3100;  0.6001] 10.63     0.27
129        melatonin      placebo  0.1783 [ 0.0690;  0.2876]  0.16     0.26
130        melatonin      placebo  0.1783 [ 0.0690;  0.2876]  0.24     0.56
132          placebo    trazodone -0.6099 [-0.8171; -0.4027]  5.20        .
132        trazodone     zolpidem  0.0933 [-0.1148;  0.3013]  0.12        .
132          placebo     zolpidem -0.5166 [-0.5850; -0.4483]  3.82        .
136      eszopiclone      placebo  0.6027 [ 0.5241;  0.6813]  6.62     0.28
137          placebo     zolpidem -0.5166 [-0.5850; -0.4483]  0.26     0.06
142 BZD-intermediate      placebo  0.9717 [ 0.8301;  1.1134]  0.22     0.04
144      eszopiclone      placebo  0.6027 [ 0.5241;  0.6813]  4.65     0.10
145          placebo    ramelteon -0.1837 [-0.2963; -0.0710]  0.11     0.22
146      eszopiclone    zopiclone  0.0392 [-0.1513;  0.2296]  0.09     0.53
149 BZD-intermediate    trazodone  0.3618 [ 0.1400;  0.5837]  7.65     0.38
153      lemborexant     zolpidem -0.1033 [-0.2075;  0.0008]  0.62        .
153          placebo     zolpidem -0.5166 [-0.5850; -0.4483]  0.48        .
153      lemborexant      placebo  0.4133 [ 0.3178;  0.5089]  0.09        .
155      lemborexant      placebo  0.4133 [ 0.3178;  0.5089]  0.20     0.46
159     daridorexant      placebo  0.2737 [ 0.1777;  0.3696]  0.00     0.49
160     daridorexant      placebo  0.2737 [ 0.1777;  0.3696]  0.09     0.37
162          placebo   quetiapine -0.0506 [-1.1412;  1.0400]  0.00     1.00
170 BZD-intermediate  eszopiclone  0.3690 [ 0.2113;  0.5267]  1.29     0.14

Results (random effects model):

              treat1       treat2     SMD             95%-CI
5            placebo     zolpidem -0.5175 [-0.6481; -0.3869]
5           zaleplon     zolpidem -0.3088 [-0.5031; -0.1145]
5            placebo     zaleplon -0.2087 [-0.4020; -0.0155]
6        eszopiclone      placebo  0.5524 [ 0.3854;  0.7193]
25           placebo     zaleplon -0.2087 [-0.4020; -0.0155]
25           placebo     zolpidem -0.5175 [-0.6481; -0.3869]
25          zaleplon     zolpidem -0.3088 [-0.5031; -0.1145]
32           placebo     zaleplon -0.2087 [-0.4020; -0.0155]
32          zaleplon     zolpidem -0.3088 [-0.5031; -0.1145]
32           placebo     zolpidem -0.5175 [-0.6481; -0.3869]
39           placebo     zolpidem -0.5175 [-0.6481; -0.3869]
43           placebo     zaleplon -0.2087 [-0.4020; -0.0155]
45           placebo   suvorexant -0.2993 [-0.5976; -0.0009]
46           placebo   suvorexant -0.2993 [-0.5976; -0.0009]
47           placebo     zolpidem -0.5175 [-0.6481; -0.3869]
48          zaleplon     zolpidem -0.3088 [-0.5031; -0.1145]
50  BZD-intermediate     zolpidem  0.3119 [ 0.0820;  0.5418]
58       eszopiclone      placebo  0.5524 [ 0.3854;  0.7193]
59           placebo     zolpidem -0.5175 [-0.6481; -0.3869]
60           doxepin      placebo  0.2920 [-0.0530;  0.6371]
63           doxepin      placebo  0.2920 [-0.0530;  0.6371]
65         melatonin      placebo  0.1397 [-0.0883;  0.3676]
67  BZD-intermediate      placebo  0.8294 [ 0.6045;  1.0543]
70         melatonin      placebo  0.1397 [-0.0883;  0.3676]
72          BZD-long    BZD-short -0.0000 [-0.8891;  0.8891]
72         BZD-short      placebo  0.0000 [-0.8891;  0.8891]
72          BZD-long      placebo  0.0000 [-0.8891;  0.8891]
77       eszopiclone      placebo  0.5524 [ 0.3854;  0.7193]
81           placebo     zolpidem -0.5175 [-0.6481; -0.3869]
94  BZD-intermediate     zolpidem  0.3119 [ 0.0820;  0.5418]
99      daridorexant     zolpidem -0.2326 [-0.4967;  0.0316]
99           placebo     zolpidem -0.5175 [-0.6481; -0.3869]
99      daridorexant      placebo  0.2849 [ 0.0434;  0.5264]
100        melatonin      placebo  0.1397 [-0.0883;  0.3676]
102          placebo     zolpidem -0.5175 [-0.6481; -0.3869]
106      eszopiclone    zopiclone  0.0409 [-0.2930;  0.3749]
111 BZD-intermediate      placebo  0.8294 [ 0.6045;  1.0543]
111 BZD-intermediate trimipramine  0.1929 [-0.4668;  0.8527]
111          placebo trimipramine -0.6365 [-1.2972;  0.0243]
112          placebo     zolpidem -0.5175 [-0.6481; -0.3869]
120      eszopiclone      placebo  0.5524 [ 0.3854;  0.7193]
123      eszopiclone      placebo  0.5524 [ 0.3854;  0.7193]
127          placebo    ramelteon -0.1719 [-0.4759;  0.1320]
128 BZD-intermediate     zolpidem  0.3119 [ 0.0820;  0.5418]
129        melatonin      placebo  0.1397 [-0.0883;  0.3676]
130        melatonin      placebo  0.1397 [-0.0883;  0.3676]
132          placebo    trazodone -0.6069 [-0.9485; -0.2654]
132        trazodone     zolpidem  0.0894 [-0.2534;  0.4323]
132          placebo     zolpidem -0.5175 [-0.6481; -0.3869]
136      eszopiclone      placebo  0.5524 [ 0.3854;  0.7193]
137          placebo     zolpidem -0.5175 [-0.6481; -0.3869]
142 BZD-intermediate      placebo  0.8294 [ 0.6045;  1.0543]
144      eszopiclone      placebo  0.5524 [ 0.3854;  0.7193]
145          placebo    ramelteon -0.1719 [-0.4759;  0.1320]
146      eszopiclone    zopiclone  0.0409 [-0.2930;  0.3749]
149 BZD-intermediate    trazodone  0.2225 [-0.1299;  0.5749]
153      lemborexant     zolpidem -0.1063 [-0.3921;  0.1795]
153          placebo     zolpidem -0.5175 [-0.6481; -0.3869]
153      lemborexant      placebo  0.4112 [ 0.1381;  0.6843]
155      lemborexant      placebo  0.4112 [ 0.1381;  0.6843]
159     daridorexant      placebo  0.2849 [ 0.0434;  0.5264]
160     daridorexant      placebo  0.2849 [ 0.0434;  0.5264]
162          placebo   quetiapine -0.0506 [-1.2081;  1.1068]
170 BZD-intermediate  eszopiclone  0.2770 [ 0.0124;  0.5416]

Number of studies: k = 48
Number of pairwise comparisons: m = 64
Number of observations: o = 15961
Number of treatments: n = 17
Number of designs: d = 22

Fixed effects model

Treatment estimate (sm = 'SMD', comparison: other treatments vs 'placebo'):
                    SMD            95%-CI     z  p-value
BZD-intermediate 0.9717 [ 0.8301; 1.1134] 13.45 < 0.0001
BZD-long         0.0000 [-0.8002; 0.8002]  0.00   1.0000
BZD-short        0.0000 [-0.8002; 0.8002]  0.00   1.0000
daridorexant     0.2737 [ 0.1777; 0.3696]  5.59 < 0.0001
doxepin          0.2676 [ 0.0659; 0.4693]  2.60   0.0093
eszopiclone      0.6027 [ 0.5241; 0.6813] 15.03 < 0.0001
lemborexant      0.4133 [ 0.3178; 0.5089]  8.48 < 0.0001
melatonin        0.1783 [ 0.0690; 0.2876]  3.20   0.0014
placebo               .                 .     .        .
quetiapine       0.0506 [-1.0400; 1.1412]  0.09   0.9275
ramelteon        0.1837 [ 0.0710; 0.2963]  3.20   0.0014
suvorexant       0.2952 [ 0.1776; 0.4128]  4.92 < 0.0001
trazodone        0.6099 [ 0.4027; 0.8171]  5.77 < 0.0001
trimipramine     0.7093 [ 0.1473; 1.2714]  2.47   0.0134
zaleplon         0.2041 [ 0.1091; 0.2992]  4.21 < 0.0001
zolpidem         0.5166 [ 0.4483; 0.5850] 14.82 < 0.0001
zopiclone        0.5636 [ 0.3575; 0.7696]  5.36 < 0.0001

Random effects model

Treatment estimate (sm = 'SMD', comparison: other treatments vs 'placebo'):
                    SMD            95%-CI    z  p-value            95%-PI
BZD-intermediate 0.8294 [ 0.6045; 1.0543] 7.23 < 0.0001 [ 0.3668; 1.2920]
BZD-long         0.0000 [-0.8891; 0.8891] 0.00   1.0000 [-1.0010; 1.0010]
BZD-short        0.0000 [-0.8891; 0.8891] 0.00   1.0000 [-1.0010; 1.0010]
daridorexant     0.2849 [ 0.0434; 0.5264] 2.31   0.0208 [-0.1865; 0.7563]
doxepin          0.2920 [-0.0530; 0.6371] 1.66   0.0972 [-0.2436; 0.8277]
eszopiclone      0.5524 [ 0.3854; 0.7193] 6.48 < 0.0001 [ 0.1167; 0.9880]
lemborexant      0.4112 [ 0.1381; 0.6843] 2.95   0.0032 [-0.0782; 0.9006]
melatonin        0.1397 [-0.0883; 0.3676] 1.20   0.2298 [-0.3245; 0.6038]
placebo               .                 .    .        .                 .
quetiapine       0.0506 [-1.1068; 1.2081] 0.09   0.9317 [-1.2091; 1.3104]
ramelteon        0.1719 [-0.1320; 0.4759] 1.11   0.2676 [-0.3365; 0.6804]
suvorexant       0.2993 [ 0.0009; 0.5976] 1.97   0.0493 [-0.2056; 0.8041]
trazodone        0.6069 [ 0.2654; 0.9485] 3.48   0.0005 [ 0.0737; 1.1401]
trimipramine     0.6365 [-0.0243; 1.2972] 1.89   0.0590 [-0.1541; 1.4271]
zaleplon         0.2087 [ 0.0155; 0.4020] 2.12   0.0343 [-0.2383; 0.6558]
zolpidem         0.5175 [ 0.3869; 0.6481] 7.77 < 0.0001 [ 0.0953; 0.9397]
zopiclone        0.5115 [ 0.1381; 0.8848] 2.69   0.0073 [-0.0440; 1.0669]

Quantifying heterogeneity / inconsistency:
tau^2 = 0.0391; tau = 0.1978; I^2 = 71.3% [60.7%; 79.0%]

Tests of heterogeneity (within designs) and inconsistency (between designs):
                     Q d.f.  p-value
Total           139.37   40 < 0.0001
Within designs   48.54   28   0.0094
Between designs  90.83   12 < 0.0001
[1] "A total of 17 treatments are included in the network."
[1] "A total of 48 studies are included in this analysis."
[1] "Estimated heterogeneity tau-squared0.04"
[1] "Global test for inconsistency, p-value 0 (Q=91, d.o.f. 12)"
[1] "File created on 2022-04-11"
